You are here

Merck KGaA

Better Together – Merck KGaA Announces Collaboration with Artios

BioSpace

Thu, 12/3/20 - 11:01 am

drug development

Merck KGaA Diversifies with First Female CEO

BioSpace

Tue, 09/29/20 - 11:27 pm

Female Executives

ESMO: Pfizer, Merck KGaA's Bavencio comes up short against placebo in risky head and neck cancer trial

Fierce Pharma

Sat, 09/19/20 - 09:20 pm

head and neck cancer

clinical trials

Merck KGaA : to Invest EUR59 Million to Expand Pharmaceutical Manufacturing at US Facility

Market Screener

Wed, 09/9/20 - 11:02 am

drug manufacturing

Big pharma spinouts grow up

EP Vantage

Tue, 09/8/20 - 10:53 am

FDA starts quick review of Merck KGaA’s MET-targeting lung cancer drug

Pharmaforum

Wed, 08/26/20 - 11:03 am

Merck KGaA picks up another anticancer bispecific from F-star

Fierce Biotech

Fri, 07/17/20 - 11:07 am

F-star Therapeutics

immuno-oncology

bispecific antibodies

Merck KGaA's manufacturing group could see billions from COVID-19 work: analyst

Fierce Pharma

Tue, 07/14/20 - 11:27 pm

drug manufacturing

Merck KGaA’s ATR cancer drug cleared for further trials after phase 1 trial success

Pharmaforum

Tue, 06/23/20 - 10:46 am

clinical trials

Marketing In another round of Merck vs. Merck, Germany-based Merck KGaA notches a win in the U.K.

Fierce Pharma

Mon, 06/1/20 - 11:39 pm

ASCO: Pfizer, Merck KGaA's Bavencio posts win in rare gynecological cancer

Fierce Pharma

Thu, 05/28/20 - 11:08 pm

gestational trophoblastic tumors

clinical trials

Newron's Merck KGaA-in licensed compound fails Rett Syndrome study, shares wilt

Endpoints

Mon, 05/4/20 - 10:32 am

clinical trials

German Merck to spend $110M on new gene therapy facility in California

BioPharma Dive

Thu, 04/23/20 - 12:00 pm

drug manufacturing

Merck KGaA amps up in gene therapy with $110M viral vector manufacturing boost

Fierce Pharma

Tue, 04/21/20 - 12:11 pm

drug manufacturing

Pharma giants including Novartis collaborate on COVID-19 therapies

Pharmaforum

Thu, 03/26/20 - 10:38 am

Boehringer Ingelheim

Gilead Sciences

In two-man race with Novartis, Merck scores first regulatory approval for targeted lung cancer drug

Endpoints

Wed, 03/25/20 - 10:45 am

non-small cell lung cancer

Merck KGaA donates multiple sclerosis med Rebif to French COVID-19 trial

Fierce Pharma

Thu, 03/19/20 - 11:43 pm

clinical trials

Bavencio from Merck KGaA, Pfizer encounters yet another trial setback

Endpoints

Fri, 03/13/20 - 11:15 am

clinical trials

head and neck cancer

Merck KGaA partners with tech firm AMCM on tablet 3D printing

Pharmaforum

Fri, 02/28/20 - 10:39 am

drug manufacturing

To challenge Ocrevus, German Merck takes on Aubagio

EP Vantage

Sun, 02/23/20 - 02:00 pm

multiple sclerosis

Pages